Eran Blaugrund Selected Research

Adiposis Dolorosa (Dercum's Disease)

12/2021	Mode of Action of RZL-012, a New Fat-Reducing Molecule.
1/2021	RZL-012, a New Fat Dissolving Molecule, Tested in Dercum's Disease Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eran Blaugrund Research Topics

Disease

2	Adiposis Dolorosa (Dercum's Disease) 12/2021 - 01/2021
1	Neoplasms (Cancer) 12/2013
1	Multiple Sclerosis 03/2006
1	Parkinson Disease (Parkinson's Disease) 10/2005
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2004
1	Ischemia 01/2002
1	Pheochromocytoma 01/2002

Drug/Important Bio-Agent (IBA)

2	RZL-012IBA 12/2021 - 01/2021
2	Monoamine Oxidase (MAO)IBA 10/2005 - 01/2002
1	Investigational DrugsIBA 12/2021
1	ChloridesIBA 12/2021
1	Gemcitabine FDA Link 12/2013
1	CytidineIBA 12/2013
1	fluorocyclopentenylcytosineIBA 12/2013
1	Neuroprotective AgentsIBA 09/2004
1	Glutamic Acid (Glutamate)FDA Link 09/2004
1	Riluzole FDA LinkGeneric 09/2004
1	Nerve Growth Factor (NGF)IBA 01/2002
1	rasagiline (Azilect)FDA Link 01/2002
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2002
1	Glucose (Dextrose)FDA LinkGeneric 01/2002
1	Oxygen (Dioxygen)IBA 01/2002
1	Selegiline (E250)FDA LinkGeneric 01/2002

Therapy/Procedure

1	Therapeutics 03/2006